Cord blood contains hematopoietic stem cells (HSCs), the building blocks of the blood and immune systems; and has for more than 30 years, been used in the proven treatment of over 80 serious conditions in stem cell transplants to rebuild the blood and immune systems, including:
- Blood disorders (sickle cell disease)
- Cancers (leukemia and lymphoma)
- Immune disorders (severe combined immunodeficiency)
- Metabolic disorders (Krabbe disease)
The cord tissue contains many different types of stem cells, including mesenchymal stem cells, epithelial and endothelial, that all have different potential uses in different ways then cord blood. They are currently being investigated in over 500 extremely promising clinical trials in areas including:
- Autoimmune (lupus and type 1 diabetes)
- Orthopedic (osteoarthritis)
- Cardiovascular (heart disease)
- Tissue and organ damage (liver and lung disease)
- Neurological (stroke and Alzheimer’s)
Stem cells from placental tissue are already being used in therapies to treat wounds and promote healing – including diabetic ulcers and eye conditions that could ultimately lead to blindness. But they also have tremendous potential for use in regenerative medicine in diseases including:
- Muscular dystrophy
- Spinal cord injury
- Heart disease
- Parkinson’s disease
- Traumatic brain injury
Amnion Placental tissue contains a powerful trio of healing properties: collagen, fibronectin, and hyaluronic acid. As well as being another source of mesenchymal stem cells, the amniotic membrane itself has a combination of growth factors, cytokines, and anti-inflammatory proteins that can help cells communicate with each other to fight disease.
- Cardiovascular conditions
- Amnion skin graft
- Brain injury
- Type 2 diabetes
- 3D printing body parts
Cord vessels are potential life-savers because they contain endothelial progenitor cells (EPCs). These special stem cells can turn into endothelial cells, which line our blood vessel walls and help in the formation of new blood vessels. With many clinical trials underway around the world, EPCs could soon provide cures for a wide range of very serious diseases, including:
- Advanced Liver Cirrhosis
- Ischemic Stroke
- Idiopathic Pulmonary Arterial Hypertension